« Back to Inflammatory Disorders

Lichenoid Skin Eruptions

» How do lichenoid eruptions differ from other papulosquamous conditions?
»What does “lichenoid” mean?
»What is the most common lichenoid skin disease?
»What anatomic locations are most often affected by Lichen planus?
»Describe the characteristic primary skin lesions of Lichen planus.
»What are the characteristic oral findings of Lichen planus?
»Describe the isomorphic response of Lichen planus.
»What causes Lichen planus?
»What are the less common presentations of Lichen planus?
»How is 20-nail dystrophy related to Lichen planus?
»Is Lichen planus associated with systemic diseases?
»What is the prognosis of Lichen planus?
»What is the primary symptom of Lichen planus?
»Describe the characteristic histopathologic features of classic Lichen planus.
»How is lichen planus treated?
»What conditions enter the differential diagnosis of an “Lichen planus-like” eruption?
»Are Lichen planus and systemic lupus erythematosus related?
»Are Lichen planus and bullous pemphigoid related?
»Why is graft-versus-host disease a consideration in Lichen planus-like eruptions?
»Describe the primary lesion of lichen nitidus.
»What are the other clinical features of lichen nitidus?
»Does lichen nitidus demonstrate a lichenoid infiltrate upon biopsy?
»What is lichen striatus?
»Discuss the natural history and prognosis of lichen striatus.
»What is lichen simplex chronicus?
»How is lichen simplex chronicus treated?

 
 
 

Is Lichen planus associated with systemic diseases?

LP has been associated with numerous disorders, but such relationships often engender controversy. Associated conditions include viral hepatitis, chronic active hepatitis, primary biliary cirrhosis, diabetes mellitus, internal malignancy, and autoimmune or connective tissue disease. The relationship to infection with hepatitis C (HCV) is controversial. The latest metaanalysis concluded that the association exists in some regions (East/Southeast Asia, South America, the Middle East, and Europe) but not in others (North America, South Asia, and Africa). At present, it is recommended that patients with LP be queried about major risks factors (IV drug use or sex with IV drug users) or minor risk factors (history of blood transfusion, male sex, and age 30 to 49 years) and that those with significant risk be screened for HCV antibodies.

Bigby, M: The relationship between lichen planus and hepatitis C clarified, Arch Dermatol 145:1048–1050, 2009.